ZECUF HERBAL COUGH REMEDY

Indications

• Cough
• Bronchitis
• Asthma
• Respiratory tract infections
• Inflammatory conditions

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The primary active components of Adhatoda, particularly vasicine and vasicinone, exhibit bronchodilator effects by relaxing the bronchial smooth muscles. They also act as mucolytics, facilitating the clearance of mucus from the respiratory tract. Furthermore, these compounds have been shown to exert anti-inflammatory effects by inhibiting the release of pro-inflammatory cytokines and mediators. This multi-faceted mechanism makes Adhatoda effective in alleviating symptoms associated with respiratory ailments.

Pharmacodynamics

Adhatoda demonstrates a range of pharmacodynamic effects, including bronchodilation, mucus secretion modulation, and anti-inflammatory action. The alkaloids enhance ciliary action in the respiratory tract, improving mucus clearance. The anti-inflammatory properties reduce airway inflammation, which is beneficial in conditions such as asthma and chronic bronchitis. Additionally, the antimicrobial activity of Adhatoda may help in preventing secondary infections in respiratory diseases.

Pharmacokinetics

The pharmacokinetics of Adhatoda have not been extensively studied. However, it is known that the active compounds are absorbed after oral administration, with effects typically observed within hours. The metabolic pathways of vasicine and other alkaloids involve hepatic metabolism, and they are likely excreted in urine. The bioavailability and half-life of these compounds require further investigation to establish precise pharmacokinetic profiles.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Dizziness
• Headache
• Skin rash

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• Potential interaction with antihypertensive medications

Precautions

• Use with caution in patients with a history of gastrointestinal disorders
• Should be used cautiously in patients with liver disease
• Monitor for potential allergic reactions

Pregnancy

Ahdatoda should be used cautiously during pregnancy. Consultation with a healthcare provider is recommended.

Breast-feeding

Safety during breastfeeding has not been established; consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried leaves
• Powdered form
• Extracts

Indications

• Respiratory tract infections
• Digestive disorders
• Urinary tract infections
• Anti-inflammatory applications
• Antimicrobial support

Dosage

Children: Refer to established herbal guidelines as no specific dosing information is available.

Adults: Refer to established herbal guidelines as no specific dosing information is available.

Mechanism of action

Cubeba contains various bioactive compounds, including essential oils, which have been shown to exhibit antimicrobial activity. The mechanism of action is thought to involve the disruption of microbial cell membranes and interference with metabolic processes, leading to cell death. Additionally, cubeba may exert anti-inflammatory effects by modulating the expression of pro-inflammatory cytokines.

Pharmacodynamics

Cubeba exhibits a range of pharmacological activities, including antimicrobial, anti-inflammatory, and analgesic properties. Its essential oil is rich in compounds such as cubebene and other terpenes, which contribute to its effects. Studies have indicated that cubeba may help alleviate respiratory conditions and improve digestive health, although more clinical research is needed to fully establish these effects.

Pharmacokinetics

The pharmacokinetics of cubeba, including its absorption, distribution, metabolism, and excretion, have not been extensively studied. However, it is presumed that the active constituents are absorbed through the gastrointestinal tract when consumed. The metabolism likely occurs via the liver, with elimination primarily through urine. Specific half-life and bioavailability data are not well-documented.

Pregnancy

There is insufficient reliable information regarding the safety of cubeba during pregnancy. It is advisable to avoid use unless benefits outweigh risks.

Breast-feeding

Limited data is available on the safety of cubeba during breastfeeding. Caution is recommended, and it should be avoided if possible.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Inflammatory conditions
• Cancer prevention and treatment
• Antioxidant therapy
• Digestive disorders
• Cardiovascular health

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing guidelines, as dosages can vary based on the formulation and clinical indication.

Mechanism of action

Curcumin acts as a scavenger of reactive oxygen species, including hydroxyl radicals and superoxide anions, and inhibits lipid peroxidation as well as peroxide-induced DNA damage. It exhibits potent anti-inflammatory and anti-carcinogenic effects by modulating various signaling molecules. Curcumin inhibits protein kinases, c-Jun/AP-1 activation, and cyclooxygenase (COX)-2 activity, impacting cellular signal transduction pathways related to growth and malignant transformation.

Pharmacodynamics

In experimental animal models, curcumin has demonstrated significant pharmacological effects, such as increasing bile flow and inhibiting inflammation and edema formation. It has been shown to decrease cell proliferation and promote apoptosis in cancer cells. Additionally, curcumin inhibits platelet aggregation induced by arachidonic acid, suggesting its role in cardiovascular health.

Pharmacokinetics

Curcumin's pharmacokinetics are characterized by low bioavailability due to rapid metabolism and systemic elimination. It undergoes extensive hepatic metabolism, leading to the production of several metabolites. The absorption of curcumin can be enhanced by co-administration with piperine. Oral bioavailability remains a challenge, which has led to the exploration of various formulations to improve its therapeutic efficacy.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Diarrhea
• Allergic reactions

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications
• May interfere with the metabolism of certain drugs due to inhibition of cytochrome P450 enzymes

Precautions

• Use with caution in patients with gallbladder disease
• Monitor patients on anticoagulant therapy
• Caution in patients with diabetes due to potential hypoglycemic effects

Pregnancy

Safety during pregnancy has not been established, caution is advised.

Breast-feeding

Curcumin may be excreted in breast milk, caution is advised.

Storage

Store in a cool, dry place away from light.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extracts

Indications

• Gastrointestinal disorders (e.g., peptic ulcers, dyspepsia)
• Respiratory conditions (e.g., cough, bronchitis)
• Inflammatory conditions (e.g., arthritis, dermatitis)
• Viral infections (e.g., hepatitis, herpes simplex)

Dosage

Children: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Adults: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Mechanism of action

Glycyrrhizin, the active compound in glabra, inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, leading to increased cortisol levels in tissues. This mechanism helps to reduce inflammation and modulate immune responses. Additionally, glabra exhibits antiviral activity by inhibiting the replication of certain viruses, possibly through interference with viral proteins and host cell interactions.

Pharmacodynamics

The pharmacodynamic effects of glabra are primarily attributed to glycyrrhizin and flavonoids present in the plant. Its anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines and pathways such as NF-κB. The compound also has expectorant properties, aiding in the relief of cough and respiratory distress by promoting mucus secretion and reducing irritation in the airways.

Pharmacokinetics

Glycyrrhizin is absorbed in the gastrointestinal tract, and its bioavailability can be influenced by the presence of other food components. Once absorbed, it undergoes hepatic metabolism, with its metabolites excreted primarily through urine. The half-life of glycyrrhizin can vary but is generally several hours, necessitating multiple doses for sustained therapeutic effects. Chronic use may lead to accumulation and potential side effects such as hypertension and hypokalemia due to its mineralocorticoid-like effects.

Pregnancy

The safety of glabra during pregnancy has not been established. It is advisable to avoid its use unless clearly needed.

Breast-feeding

There is limited information on the excretion of glabra in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from moisture and direct light. Keep out of reach of children.

Indications

• Adrenal insufficiency
• Chronic inflammatory conditions

Mechanism of action

Glycyrrhizin, the primary active component of Glycyrrhiza, exerts its effects primarily through inhibition of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This inhibition prevents the conversion of active cortisol to inactive cortisone, leading to increased cortisol levels. Elevated cortisol mimics the effects of aldosterone, resulting in sodium retention, potassium excretion, and increased blood pressure. Additionally, licorice has anti-inflammatory and antiviral properties attributed to its ability to modulate various immune pathways and inhibit viral replication.

Pharmacodynamics

The pharmacodynamic effects of Glycyrrhiza include anti-inflammatory, antiviral, and immunomodulatory activities. Glycyrrhizin has been shown to reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators. Its potential antiviral properties are particularly noted in viral infections such as hepatitis C and COVID-19, where it may inhibit viral replication. Furthermore, its ability to enhance the effects of corticosteroids can be beneficial in treating conditions associated with adrenal insufficiency or chronic inflammation.

Pharmacokinetics

Glycyrrhizin is absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours after oral administration. It undergoes extensive metabolism in the liver, primarily through conjugation processes, leading to the formation of glycyrrhetic acid as a major metabolite. The elimination half-life of glycyrrhizin is approximately 6-8 hours. Glycyrrhiza components are excreted in urine predominantly as conjugated forms. Long-term use can lead to accumulation and potential side effects due to its mineralocorticoid-like effects.

Contra-indications

• Hypertension
• Hypokalemia
• Severe kidney disease
• Pregnancy (due to hormonal effects)

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headaches
• Fatigue
• Muscle weakness
• Cardiac arrhythmias (with excessive use)

Interactions

• May enhance the effects of corticosteroids
• May increase the risk of hypokalemia with diuretics
• May interact with anticoagulants, increasing the risk of bleeding
• May affect the metabolism of drugs metabolized by CYP3A4

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure and potassium levels during prolonged use
• Not recommended for long-term use without medical supervision

Pregnancy

Glycyrrhiza should be avoided during pregnancy as it may cause hormonal effects that could affect fetal development.

Breast-feeding

Consult a healthcare provider before use while breastfeeding, as safety is not well established.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Dried root
• Extracts (liquid and powdered)
• Teas
• Capsules

Indications

• Rheumatoid arthritis
• Osteoarthritis
• Acute gout
• Ankylosing spondylitis
• Postoperative pain
• Tendinitis
• Bursitis

Dosage

Children: Refer to the BNF for Children for specific dosage recommendations.

Adults: Refer to the BNF for specific dosage recommendations.

Mechanism of action

Indicum primarily exerts its effects by non-selectively inhibiting the cyclooxygenase (COX-1 and COX-2) enzymes. This inhibition decreases the production of prostaglandins, which are lipid compounds that mediate inflammation, pain, and fever. By reducing prostaglandin synthesis, Indicum alleviates symptoms associated with inflammatory conditions.

Pharmacodynamics

The pharmacodynamics of Indicum involve its ability to modulate inflammatory processes through the suppression of prostaglandin synthesis. This leads to decreased vasodilation, reduced permeability of blood vessels, and diminished pain signaling. The onset of analgesic effects typically occurs within 30 minutes to 1 hour after oral administration, with a duration of action lasting several hours, depending on the formulation used.

Pharmacokinetics

Indicum is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 1 to 2 hours after oral administration. It is highly protein-bound (about 90-95%) and has a volume of distribution of approximately 0.1 to 0.3 L/kg. The drug is extensively metabolized in the liver through hydroxylation and conjugation, with a half-life ranging from 4 to 5 hours. The metabolites are primarily excreted via the kidneys, with a small amount excreted in the bile.

Indications

• Respiratory conditions such as bronchitis
• Cough relief
• Digestive disorders
• Antimicrobial support
• Anti-inflammatory purposes

Dosage

Children: Refer to herbal medicine guidelines and consult with a healthcare professional for appropriate dosing.

Adults: Refer to herbal medicine guidelines and consult with a healthcare professional for appropriate dosing.

Mechanism of action

The primary active components of Inula, including inulin and essential oils, exhibit anti-inflammatory, antimicrobial, and expectorant properties. The mechanism of action is not fully understood, but inulin is known to stimulate the immune system, promote the secretion of mucus in the respiratory tract, and facilitate the expulsion of mucus, thereby aiding in the relief of coughs and respiratory congestion.

Pharmacodynamics

Inula demonstrates a range of pharmacodynamic effects, primarily through its active constituents. Its expectorant properties enhance mucus clearance in the airways, while its anti-inflammatory effects may reduce irritation in respiratory tissues. Additionally, the antimicrobial activity of Inula may help in managing infections, particularly those affecting the respiratory system and gastrointestinal tract.

Pharmacokinetics

The pharmacokinetics of Inula are not extensively characterized in scientific literature. However, it is believed that the active compounds are absorbed in the gastrointestinal tract, with inulin being a soluble fiber that can influence gut microbiota. The metabolism and excretion pathways of Inula's constituents remain largely unexplored, necessitating further research to clarify these aspects.

Pregnancy

There is insufficient reliable information regarding the safety of Inula during pregnancy. It is advisable to avoid its use unless prescribed by a healthcare professional.

Breast-feeding

Due to a lack of adequate studies, the safety of Inula during breastfeeding is not established. Caution is advised, and its use should be avoided unless necessary.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Anxiety
• Insomnia
• Nutritional supplement
• Antioxidant support
• Immune system support

Dosage

Children: Refer to authoritative sources for specific dosing information.

Adults: Refer to authoritative sources for specific dosing information.

Mechanism of action

The mechanism of action of Longan is not fully elucidated, but it is believed to exert its effects through the modulation of neurotransmitters, particularly influencing serotonin and gamma-aminobutyric acid (GABA) pathways. The fruit is rich in antioxidants, which may contribute to its protective effects against oxidative stress.

Pharmacodynamics

Longan is known for its high content of vitamins, minerals, and antioxidants, including vitamin C, B vitamins, and polyphenols. These compounds may enhance immune function, promote nervous system health, and improve skin health. Its calming effects may be attributed to constituents that influence neurotransmitter activity.

Pharmacokinetics

The pharmacokinetics of Longan is not well-studied, but as a food source, it is likely to be absorbed through the gastrointestinal tract. The bioavailability of its active compounds may vary depending on preparation methods (fresh, dried, or processed). The metabolism and excretion pathways are not clearly defined in the literature.

Pregnancy

Insufficient data on the safety of longa during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Insufficient data on the excretion of longa in human milk. Caution is advised when using during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Digestive disorders
• Respiratory conditions
• Antimicrobial therapy
• Anti-inflammatory support
• Stress relief

Dosage

Children: Refer to specific herbal preparation guidelines; there is no standard paediatric dose for Ocimum.

Adults: Refer to specific herbal preparation guidelines; there is no standard adult dose for Ocimum.

Mechanism of action

The pharmacological effects of Ocimum are primarily attributed to its essential oil constituents, such as eugenol, linalool, and other phenolic compounds. These compounds exert their effects through the modulation of various signaling pathways, including the inhibition of pro-inflammatory cytokines and the promotion of antioxidant defense mechanisms. The antimicrobial properties are believed to arise from the disruption of microbial cell membranes and interference with metabolic processes.

Pharmacodynamics

Ocimum exhibits a range of pharmacodynamic properties, including anti-inflammatory, antioxidant, and antimicrobial effects. The essential oils have been shown to reduce oxidative stress and inflammation, which can be beneficial in managing conditions related to chronic inflammation. Additionally, the herb may promote digestive health by enhancing gastrointestinal motility and reducing symptoms of dyspepsia.

Pharmacokinetics

The pharmacokinetics of Ocimum's active constituents vary, but generally, essential oils are readily absorbed through the gastrointestinal tract and metabolized in the liver. The bioavailability of these compounds can be influenced by the method of preparation (e.g., fresh, dried, or extract form) and the presence of other food components. The elimination half-life is also variable and dependent on the specific compounds involved.

Pregnancy

Limited data is available on the safety of Ocimum during pregnancy. It is advisable to use with caution and consult a healthcare provider.

Breast-feeding

Due to lack of sufficient evidence, it is recommended to consult a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Dried leaves
• Tincture
• Powder

Indications

• Wound healing
• Oral health (e.g., gingivitis, mouth ulcers)
• Anti-inflammatory conditions
• Gastrointestinal disorders (e.g., dyspepsia)
• Antimicrobial applications

Dosage

Children: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Adults: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Mechanism of action

The active compounds in officinale, such as resins and essential oils, exhibit their effects through various mechanisms, including the inhibition of pro-inflammatory cytokines and modulation of immune responses. These actions contribute to its analgesic and antimicrobial properties, making it beneficial in treating wounds and oral infections.

Pharmacodynamics

Myrrh has demonstrated a range of pharmacodynamic effects, including analgesia, anti-inflammatory activity, and antimicrobial action. The resin contains various terpenoids and phenolic compounds, which interact with biological pathways to exert these effects. Studies suggest that myrrh may inhibit the growth of certain bacteria and fungi, as well as reduce inflammation by blocking the synthesis of pro-inflammatory mediators.

Pharmacokinetics

The pharmacokinetics of myrrh are not well-defined due to variability in preparation and formulation. However, it is generally believed that the compounds are absorbed through the gastrointestinal tract when ingested, with some components potentially being metabolized in the liver. The onset of action may vary depending on the method of administration, with topical applications likely providing localized effects.

Pregnancy

Safety during pregnancy has not been established; consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before using, as safety during breastfeeding is not well established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Uncomplicated malaria caused by Plasmodium falciparum

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Piperaquine acts by interfering with the heme detoxification process in the malaria parasite. It accumulates within the food vacuole of the parasite and inhibits the conversion of toxic heme into non-toxic hemozoin. This accumulation of free heme leads to oxidative stress and cellular damage, ultimately resulting in the death of the parasite.

Pharmacodynamics

Piperaquine demonstrates a dose-dependent response in its antimalarial activity. It is effective against the asexual blood stages of Plasmodium species, with a prolonged half-life that allows for once-weekly dosing in some regimens. The drug's efficacy is influenced by the rate of parasite clearance and the patient's immune response.

Pharmacokinetics

Piperaquine is well-absorbed following oral administration, with peak plasma concentrations typically occurring within 4 to 6 hours. It has a long elimination half-life, which can range from 10 to 30 days, allowing for sustained plasma levels. The drug is metabolized in the liver and excreted primarily in the feces, with a smaller fraction eliminated in the urine. Its pharmacokinetics can be significantly affected by drug interactions, particularly those that alter hepatic metabolism.

Interactions

• grapefruit juice: Severe (increases concentration)
• mitotane: Severe (decreases concentration)
• St. John's wort: Severe (decreases concentration)
• rifampicin: Severe (decreases concentration)
• dronedarone: Unknown (increases concentration)
• cobicistat: Unknown (increases concentration)
• crizotinib: Unknown (increases concentration)
• idelalisib: Unknown (increases concentration)
• imatinib: Unknown (increases concentration)
• letermovir: Unknown (increases concentration)

Pregnancy

Consult with a healthcare professional regarding the use of piper during pregnancy.

Breast-feeding

Consult with a healthcare professional regarding the use of piper during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• {'name': 'Piperaquine', 'class': 'Penicillins', 'molecular_formula': 'C38H36N4O4'}

Indications

• Menopausal symptoms
• Hot flashes
• Menstrual irregularities
• Mood swings associated with menopause

Dosage

Children: There is insufficient evidence to support the use of racemosa in children; refer to a healthcare professional for appropriate guidance.

Adults: Refer to a healthcare professional for appropriate dosing guidance, as specific doses can vary based on formulation and indication.

Mechanism of action

The exact mechanism of action of racemosa is not fully understood. However, it is believed to exert its effects by interacting with estrogen receptors and modulating the hypothalamic-pituitary-ovarian axis, which may help in balancing hormone levels. It may also possess anti-inflammatory properties and influence neurotransmitter activity, contributing to its effects on mood and well-being.

Pharmacodynamics

Racemosa exhibits phytoestrogenic activity, which means it can mimic estrogen in the body, potentially alleviating menopausal symptoms. Its anti-inflammatory properties may help reduce discomfort associated with menstrual and menopausal symptoms. Additionally, its potential effects on serotonin pathways may influence mood stabilization.

Pharmacokinetics

Racemosa is typically administered orally and is absorbed in the gastrointestinal tract. The bioavailability of its active compounds can be affected by factors such as formulation and individual metabolism. The specific pharmacokinetic parameters like half-life, volume of distribution, and clearance are not well-documented due to the variability in herbal preparations and individual responses.

Pregnancy

The safety of racemosa during pregnancy has not been well established, and it is recommended to avoid use unless specifically advised by a healthcare provider.

Breast-feeding

Due to a lack of sufficient data, it is advisable to avoid the use of racemosa while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Dosage

Children: Specific dosing information for paediatric patients is not available. It is advisable to consult paediatric dosing guidelines or healthcare professionals for appropriate dosing recommendations.

Adults: Specific dosing information for adults is not available. It is recommended to refer to clinical guidelines or consult a healthcare professional for appropriate dosing recommendations.

Mechanism of action

The exact mechanism of action of Sanctum is currently unclear. However, it may involve modulation of specific biochemical pathways or receptors that influence physiological processes related to its therapeutic effects. Further studies are needed to elucidate its pharmacological properties.

Pharmacodynamics

Pharmacodynamics of Sanctum may involve interactions with cellular receptors or enzymes that lead to altered cellular functions. These interactions could affect various biological systems, potentially resulting in therapeutic outcomes. The specific pharmacodynamic profile remains to be characterized.

Pharmacokinetics

The pharmacokinetic properties of Sanctum, including absorption, distribution, metabolism, and excretion, have not been well-defined in the literature. It is essential to conduct comprehensive studies to determine how the drug behaves in the body and its potential impact on therapeutic effectiveness.

Indications

• Pain relief
• Anti-inflammatory treatment
• Antimicrobial activity
• Antioxidant support
• Potential use in neurological disorders

Dosage

Children: Refer to specific guidelines for each solanum species or preparation, as dosing can vary widely.

Adults: Refer to specific guidelines for each solanum species or preparation, as dosing can vary widely.

Mechanism of action

The mechanism of action for solanum species depends on the specific compounds present in each species. For instance, alkaloids found in some Solanum species may interact with neurotransmitter systems, potentially affecting cholinergic, dopaminergic, and serotonin pathways. Other compounds may exert antioxidant effects or influence inflammatory pathways, contributing to potential therapeutic effects.

Pharmacodynamics

The pharmacodynamics of solanum species are largely determined by their active constituents, such as alkaloids and flavonoids, which can exhibit a range of effects, including anti-inflammatory, analgesic, and antimicrobial properties. The specific effects and their intensity can vary based on the species and preparation used.

Pharmacokinetics

Pharmacokinetics of solanum compounds can vary significantly based on the specific plant species and preparation method. Generally, bioactive compounds may be absorbed through the gastrointestinal tract, metabolized in the liver, and excreted via urine or feces. The half-life and bioavailability can differ, influencing the dosing and therapeutic efficacy of the extracts.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Neurological symptoms (in cases of toxicity)

Precautions

• Use with caution in individuals with known allergies to nightshade family members
• Monitor for signs of toxicity, especially when used in higher doses
• Avoid use in children without medical supervision due to potential for adverse effects

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

Caution is advised as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from light and moisture. Keep out of reach of children.

Formulations

• Dried leaves
• Powdered extracts
• Tinctures

Indications

• Asthma
• Chronic bronchitis
• Cough
• Respiratory tract infections

Dosage

Children: Refer to relevant clinical guidelines and herbal medicine references for appropriate dosing information.

Adults: Refer to relevant clinical guidelines and herbal medicine references for appropriate dosing information.

Mechanism of action

The mechanism of action of vasicine involves the inhibition of inflammatory mediators and the relaxation of bronchial smooth muscle. This results in bronchodilation, which helps alleviate symptoms of bronchospasm. Additionally, vasicine has been shown to possess antitussive properties, reducing cough and promoting the expulsion of mucus from the respiratory tract.

Pharmacodynamics

Vasica exhibits anti-inflammatory, bronchodilator, and expectorant effects. Its active compounds facilitate the relaxation of the bronchial muscles, enhance mucociliary clearance, and suppress cough reflexes. The pharmacological actions contribute to improved airway patency and respiratory function in patients with obstructive airway diseases.

Pharmacokinetics

The pharmacokinetics of vasicine include its absorption, distribution, metabolism, and excretion, though specific data on its pharmacokinetic profile are limited. Vasicine is likely absorbed through the gastrointestinal tract and may undergo hepatic metabolism. Its elimination half-life and specific metabolic pathways have not been extensively studied, warranting further research to fully elucidate these aspects.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Headache
• Allergic reactions

Precautions

• Monitor for allergic reactions in patients with a history of hypersensitivity
• Use with caution in patients with gastrointestinal disorders

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and after assessing risks versus benefits.

Breast-feeding

It is unknown whether vasica is excreted in human milk. Caution is advised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Liquid extract
• Syrup

Indications

• Nausea and vomiting associated with motion sickness
• Nausea in pregnancy (morning sickness)
• Post-operative nausea and vomiting
• Osteoarthritis and other inflammatory joint conditions
• Dyspepsia and gastrointestinal discomfort

Dosage

Children: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Adults: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Mechanism of action

Ginger contains bioactive compounds, including gingerol and shogaol, which exhibit anti-inflammatory and antioxidant effects. The mechanism of action involves the inhibition of pro-inflammatory cytokines and enzymes, such as cyclooxygenase and lipoxygenase, leading to reduced inflammation. Ginger also enhances gastrointestinal motility and may exert a protective effect on the gastric mucosa.

Pharmacodynamics

The pharmacodynamic effects of ginger are primarily attributed to its active constituents, which modulate various physiological pathways. Gingerol and shogaol have been shown to influence the release of serotonin and other neurotransmitters, thereby alleviating nausea. Additionally, ginger's antioxidant properties help to mitigate oxidative stress in cells, contributing to its anti-inflammatory effects.

Pharmacokinetics

Ginger is rapidly absorbed in the gastrointestinal tract, with peak plasma concentrations of its active compounds occurring within 1-2 hours after ingestion. The bioavailability of gingerol and shogaol can be affected by the formulation and method of preparation (e.g., fresh, dried, or as an extract). The elimination half-life of these compounds is variable, with metabolism occurring primarily in the liver. They are excreted through urine and bile, and their effects can last for several hours.

Adverse effects

• Gastrointestinal discomfort
• Heartburn
• Nausea
• Diarrhea
• Skin irritation

Interactions

• Anticoagulants (e.g., warfarin)
• Antidiabetic medications
• Antihypertensive medications

Precautions

• Use with caution in patients with gallstones
• May affect blood sugar levels; monitor in diabetic patients
• May increase the risk of bleeding when used with anticoagulants

Pregnancy

Zingiber (ginger) is generally considered safe in food amounts during pregnancy. However, high doses should be avoided due to potential risks.

Breast-feeding

Zingiber is likely safe in food amounts while breastfeeding, but high doses should be avoided.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Dried root
• Powder
• Capsules
• Tinctures
• Essential oil

Mechanism of action

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2. Curcumin, a polyphenolic natural product, exhibits therapeutic activity against a number of diseases, attributed mainly to its chemical structure and unique physical, chemical, and biological properties. It is a diferuloyl methane molecule [1,7-bis (4-hydroxy-3- methoxyphenyl)-1,6-heptadiene-3,5-dione)] containing two ferulic acid residues joined by a methylene bridge. It has three important functionalities: an aromatic o-methoxy phenolic group, alpha, beta-unsaturated beta-diketo moiety and a seven carbon linker. Extensive research in the last two decades has provided evidence for the role of these different functional groups in its crucial biological activities. A few highlights of chemical structural features associated with the biological activity of curcumin are: The o-methoxyphenol group and methylenic hydrogen are responsible for the antioxidant activity of curcumin, and curcumin donates an electron/ hydrogen atom to reactive oxygen species. Curcumin interacts with a number of biomolecules through non-covalent and covalent binding. The hydrogen bonding and hydrophobicity of curcumin, arising from the aromatic and tautomeric structures along with the flexibility of the linker group are responsible for the non-covalent interactions. The alpha, beta-unsaturated beta-diketone moiety covalently interacts with protein thiols, through Michael reaction. The beta-diketo group forms chelates with transition metals, thereby reducing the metal induced toxicity and some of the metal complexes exhibit improved antioxidant activity as enzyme mimics. New analogues with improved activity are being developed with modifications on specific functional groups of curcumin... The present study demonstrates that curcumin acts as pro-oxidant and sensitizes human lung adenocarcinoma epithelial cells (A549) to apoptosis via intracellular redox status mediated pathway. Results indicated that curcumin induced cell toxicity (light microscopy and MTT assay) and apoptosis (AnnexinV-FITC/PI labeling and caspase-3 activity) in these cells. These events seem to be mediated through generation of reactive oxygen species (ROS) and superoxide radicals (SOR) and enhanced levels of lipid peroxidation. These changes were accompanied by increase in oxidized glutathione (GSSG), reduced glutathione (GSH) and gamma-glutamylcysteine synthetase (gamma-GCS) activity, but decrease in GSH/GSSG ratio. The induction of apoptosis and decrease in GSH/GSSG ratio was also accompanied by sustained phosphorylation and activation of p38 mitogen activated protein kinase (MAPK). On the other hand, addition of N-acetyl cysteine (NAC), an antioxidant, blocked the curcumin-induced ROS production and rescued malignant cells from curcumin-induced apoptosis through caspase-3 deactivation. However, L-buthionine sulfoximine (BSO), a GSH synthesis blocking agent, further enhanced curcumin-induced ROS production and apoptosis in A549 cells. Decreased GSH/GSSG ratio seems to be a crucial factor for the activation of MAPK signaling cascade by curcumin. The study therefore, provides an insight into the molecular mechanism involved in sensitization of lung adenocarcinoma cells to apoptosis by curcumin. Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activiti

Pharmacodynamics

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.